Medherant awarded manufacturing grant from Innovate UK
Medherant has been awarded a grant by Innovate UK to help it upscale production of its TEPI Patch drug delivery system for clinical trials.
Read More
Tag: Medherant
Medherant raises £3.8 million for transdermal patch
Coventry, UK-based Medherant has raised £3.8 million in its latest funding round to help further development of its ibuprofen TEPI Patch.
Read More
Medherant secures funds of £1.5m for transdermal patch
Coventry, UK-based University of Warwick spin-out Medherant has secured funding of £1.5 million to fuel further development of its novel drug patch delivery technology.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
